Literature DB >> 7954547

Diuretic resistance: mechanisms and therapeutic strategies.

D C Brater1.   

Abstract

The mechanism(s) responsible for diuretic resistance differ in different clinical conditions. Renal insufficiency is a prototype of a pharmacokinetic mechanism wherein the disease causes decreased delivery of diuretic to its urinary site of action. Hepatic cirrhosis, on the other hand, is a prototype of a pharmacodynamic mechanism wherein normal amounts of diuretic reach the site of action but nephron response is subnormal. The mechanism of this effect is unknown. In congestive heart failure and in nephrotic syndrome, both pharmacokinetic and pharmacodynamic mechanisms occur. The different mechanisms of diuretic resistance in these various diseases dictate specific therapeutic strategies for each clinical condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954547     DOI: 10.1159/000176458

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

Review 1.  Use of diuretics in cardiovascular diseases: (1) heart failure.

Authors:  S U Shah; S Anjum; W A Littler
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

Review 2.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure.

Authors:  Ruchit A Shah; Vijayakumar Subban; Anitha Lakshmanan; Srinivasan Narayanan; Kalaichelvan Udhayakumaran; Balaji Pakshirajan; Jaishankar Krishnamoorthy; Kalidass Latchumanadhas; Ezhilan Janakiraman; Ajit S Mullasari
Journal:  Indian Heart J       Date:  2014-04-18

Review 4.  Clinical pharmacokinetics and pharmacodynamics of torasemide.

Authors:  H Knauf; E Mutschler
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

5.  Fractional excretion of sodium and its association with prognosis of decompensated heart failure patients.

Authors:  Dinanath Kumar; Rajeev Bagarhatta
Journal:  J Clin Diagn Res       Date:  2015-04-01

6.  Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.

Authors:  H Knauf; E Mutschler; H Velazquez; G Giebisch
Journal:  Eur J Clin Pharmacol       Date:  2009-02-20       Impact factor: 2.953

7.  High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.

Authors:  Salvatore Paterna; Sergio Fasullo; Pietro Di Pasquale
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  Role of diuretics and ultrafiltration in congestive heart failure.

Authors:  Dmitry Shchekochikhin; Fawaz Al Ammary; Jo Ann Lindenfeld; Robert Schrier
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-04

9.  Management of Diabetes Associated with Nephrotic Syndrome: Therapeutic Potential of Dapagliflozin for Protracted Volume Retention.

Authors:  Toshimi Imai; Tetsu Akimoto; Chiharu Ito; Takahiro Masuda; Daisuke Nagata
Journal:  Drug Target Insights       Date:  2015-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.